Metabolomics Market Size

Metabolomics Market size was over USD 2.56 billion in 2024 and is poised to cross USD 12.68 billion by the end of 2037, witnessing more than 13.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of metabolomics is estimated at USD 2.83 billion.

The increase in the adoption of metabolomics in precision medicine and the advancement of diagnostics to determine chronic diseases drive market growth during the forecast period. The increase in R&D expenditure in the pharmaceutical and biopharmaceutical industry and technological advancements in analytical techniques are expected to boost market growth. Over the past two decades, healthcare spending has increased significantly, reaching USD 8.5 trillion, or 9.8% of global GDP.

Using high-throughput analytical techniques, metabolomics researches the metabolome of cells, biofluids, tissues, or organisms to identify and measure changes in low molecular weight exogenous and endogenous compounds linked to disease processes. Multiple analytical techniques are needed given the complexity of the metabolome and the wide range of physiochemical characteristics of the metabolites. Nuclear magnetic resonance (NMR) and mass spectrometry (MS), along with separation methods including liquid chromatography (LC), gas chromatography (GC), and supercritical fluid chromatography (SFC), are the two analytical platforms that are used most frequently. From as little as 10 mg of tissue, 50 L of urine, and 500,000 cells, liquid chromatography (LC) combined with high-resolution MS systems to routinely detect and quantify dozens of metabolic characteristics. For instance, a conventional LC-MS-based metabolomics study with 30 samples typically generates more than 10 GB of data.